Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 560: 105-111, 2021 06 30.
Artigo em Inglês | MEDLINE | ID: mdl-33984767

RESUMO

Anti-prion effects of cellulose ether (CE) are reported in rodents, but the molecular mechanism is fully unknown. Here, we investigated the genetic background of CE effectiveness by proteomic and genetic analysis in mice. Proteomic analysis in the two mouse lines showing a dramatic difference in CE effectiveness revealed a distinct polymorphism in the glia maturation factor ß gene. This polymorphism was significantly associated with the CE effectiveness in various prion-infected mouse lines. Sequencing of this gene and its vicinity genes also revealed several other polymorphisms that were significantly related to the CE effectiveness. These polymorphisms are useful as genetic markers for finding more suitable mouse lines and exploring the genetic factors of CE effectiveness.


Assuntos
Fator de Maturação da Glia/genética , Derivados da Hipromelose/uso terapêutico , Doenças Priônicas/tratamento farmacológico , Animais , Encéfalo/metabolismo , Marcadores Genéticos , Genômica , Masculino , Camundongos , Polimorfismo Genético , Doenças Priônicas/genética , Doenças Priônicas/metabolismo , Proteômica
2.
Carbohydr Polym ; 337: 122163, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-38710557

RESUMO

Prion diseases are fatal transmissible neurodegenerative disorders. Among known anti-prions, hydroxypropyl methylcellulose compounds (HPMCs) are unique in their chemical structure and action. They have several excellent anti-prion properties but the effectiveness depends on the prion-infected mouse model. In the present study, we investigated the effects of stearoxy-modified HPMCs on prion-infected cells and mice. Stearoxy modification improved the anti-prion efficacy of HPMCs in prion-infected cells and significantly prolonged the incubation period in a lower HPMC-responding mouse model. However, stearoxy modification showed no improvement over nonmodified HPMCs in an HPMC-responding mouse model. These results offer a new line of inquiry for use with prion-infected mice that do not respond well to HPMCs.


Assuntos
Derivados da Hipromelose , Doenças Priônicas , Animais , Derivados da Hipromelose/química , Camundongos , Doenças Priônicas/tratamento farmacológico , Modelos Animais de Doenças
3.
Mol Neurobiol ; 61(7): 4705-4711, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38114760

RESUMO

Prion diseases are fatal transmissible neurodegenerative disorders. Tremendous efforts have been made for prion diseases; however, no effective treatment is available. Several anti-prion compounds have a preference for which prion strains or prion-infected animal models to target. Styrylbenzoazole compound called cpd-B is effective in RML prion-infected mice but less so in 263K prion-infected mice, whereas hydroxypropyl methylcellulose is effective in 263K prion-infected mice but less so in RML prion-infected mice. In the present study, we developed a combination therapy of cpd-B and hydroxypropyl methylcellulose expecting synergistic effects in both RML prion-infected mice and 263K prion-infected mice. A single subcutaneous administration of this combination had substantially a synergistic effect in RML prion-infected mice but had no additive effect in 263K prion-infected mice. These results showed that the effect of cpd-B was enhanced by hydroxypropyl methylcellulose. The complementary nature of the two compounds in efficacy against prion strains, chemical properties, pharmacokinetics, and physical properties appears to have contributed to the effective combination therapy. Our results pave the way for the strategy of new anti-prion agents.


Assuntos
Derivados da Hipromelose , Doenças Priônicas , Animais , Doenças Priônicas/tratamento farmacológico , Doenças Priônicas/patologia , Derivados da Hipromelose/química , Camundongos , Quimioterapia Combinada , Benzoxazóis/farmacologia , Benzoxazóis/administração & dosagem , Benzoxazóis/farmacocinética , Benzoxazóis/uso terapêutico , Proteínas PrPSc/metabolismo , Sinergismo Farmacológico
4.
Biochim Biophys Acta Gen Subj ; 1866(4): 130094, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-35065183

RESUMO

BACKGROUND: Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. METHODS: Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. RESULTS: In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers. CONCLUSIONS: Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively. GENERAL SIGNIFICANCE: The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities.


Assuntos
Curcumina , Príons , Linhagem Celular , Curcumina/farmacologia , Proteínas PrPSc/metabolismo , Proteínas Priônicas , Príons/química , Príons/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA